Practice ReportsResponse to the US FDA LeadCare Testing Systems Recall and CDC Health AlertMason, Jacquelyn PhD, MS; Ortiz, Denise MPH; Pappas, Siobhan PhD; Quigley, Susan BA; Yendell, Stephanie DVM, MPH; Ettinger, Adrienne S. ScD, MPH, MSAuthor Information Lead Poisoning Prevention and Environmental Health Tracking Branch, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Mason and Ettinger); Connecticut Department of Public Health, Hartford, Connecticut (Ms Ortiz); New Jersey Department of Health, Trenton, New Jersey (Dr Pappas); Oklahoma State Department of Health, Oklahoma City, Oklahoma (Ms Quigley); and Minnesota Department of Health, St Paul, Minnesota (Dr Yendell). Correspondence: Jacquelyn Mason, PhD, MS, Lead Poisoning Prevention and Environmental Health Tracking Branch, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F-61, Atlanta, GA 30341 ([email protected]). The authors acknowledge the contributions of Lori Yearout, MPH, Oklahoma State Department of Health; Eva Trinh, PhD, MPH, of the Lead Poisoning Prevention and Environmental Health Tracking Branch, CDC; Jeffery M. Jarrett, MS; Jerry Thomas, MD; Kathleen Caldwell, PhD; and Robert L. Jones, PhD; all of the Division of Laboratory Sciences, National Center for Environmental Health at CDC.The findings and conclusions in this study are those of the authors and do not necessarily represent the views of the US Department of Health & Human Services, or the US Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not constitute endorsement by the US Department of Health & Human Services, or the US Centers for Disease Control and Prevention.The authors declare no conflicts of interest. Journal of Public Health Management and Practice: January/February 2019 - Volume 25 - Issue - p S91-S97 doi: 10.1097/PHH.0000000000000875 Buy Metrics Abstract On May 17, 2017, the Food and Drug Administration issued a safety recall for the Magellan Diagnostics' LeadCare Testing Systems due to the potential for inaccurately low blood lead test results when used with venous blood samples. Concurrently, the Centers for Disease Control and Prevention (CDC) issued a health alert with retesting recommendations for specific high-risk populations. The purpose of the CDC retesting recommendations was to help identify high-risk individuals so that those potentially impacted by falsely low test results could be retested and receive appropriate follow-up care. The CDC's Lead Poisoning Prevention Program sought to understand how the recall and recommendations impacted state and local public health agencies. Childhood lead poisoning prevention programs (CLPPPs) in state and local public health agencies collect blood lead test results for children and had a lead role in identifying children for retesting. Case studies are presented that highlight the experiences of 4 state CLPPPs in responding to the recall and recommendations. Collectively, the case studies point to several lessons learned, including the importance of (1) having a well-functioning surveillance system in place prior to a serious incident; (2) having a clear understanding of the roles partners play in the continuum of care for children potentially exposed to lead; and (3) ensuring effective communications with all staff, both internal and external, to public health agencies that have a role in responding to a serious incident. The ability to respond to public health emergencies or other serious incidents takes the combined effort of federal, state, and local public health agencies as well as others in the health care delivery system. The CDC will continue to support state and local lead poisoning prevention programs so that they have the information and tools they need to address and prevent the health effects of lead exposures in communities. © 2019 Wolters Kluwer Health, Inc. All rights reserved.